Safety and Efficacy of Ciclesonide in Pediatric patients (6 to 11 years of age) with Seasonal Allergic Rhinitis (BY9010/M1-417)

Exclusion Criteria

• - Pregnancy, nursing, or plans to become pregnant or donate gametes for in vitro fertilization
• - Participation in any investigational drug trial within the 30 days preceding the Screening Visit
• - A known hypersensitivity to any corticosteroid or any of the ingredients in the study drug formulation
• - Plans to travel outside the study area (the known pollen area for the investigative site) for 24 hours or more during the final 7 days of the baseline period
• - Plans to travel outside the study area (the known pollen area for the investigative site) for more than 2 consecutive days OR more than 3 days total during the treatment period
• - Use of any prohibited concomitant medications
• - Non-vaccinated exposure to or active infection with chickenpox or measles within the 21 days preceding the Screening Visit
• - Use of antiepileptic drugs for epilepsy within 30 days of the Screening Visit
• - Study participation by more than one patient from the same household